wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42503679-9EFE0101-993A-4187-9517-4B9A15ED6ACC
Q42503679-9EFE0101-993A-4187-9517-4B9A15ED6ACC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42503679-9EFE0101-993A-4187-9517-4B9A15ED6ACC
Key Survival Factor, Mcl-1, Correlates with Sensitivity to Combined Bcl-2/Bcl-xL Blockade.
P2860
Q42503679-9EFE0101-993A-4187-9517-4B9A15ED6ACC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42503679-9EFE0101-993A-4187-9517-4B9A15ED6ACC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2c726f4a37cb2204424f4341095dcb03e28a683a
P2860
Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+ lymphoid malignancies